Tubulin polymerization-IN-9

Modify Date: 2024-01-12 09:58:07

Tubulin polymerization-IN-9 Structure
Tubulin polymerization-IN-9 structure
Common Name Tubulin polymerization-IN-9
CAS Number 2485020-93-5 Molecular Weight 420.32
Density N/A Boiling Point N/A
Molecular Formula C19H19NO5Se Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Tubulin polymerization-IN-9


Tubulin polymerization-IN-9 is a potent tubulin inhibitor with IC50 of 1.82 μM. Tubulin polymerization-IN-9 causes cell cycle arrest at G2/M phase, and induces cell apoptosis and depolarized mitochondria of K562 cells. Tubulin polymerization-IN-9 has potent anti-vascular and antitumor activities[1].

 Names

Name Tubulin polymerization-IN-9

 Tubulin polymerization-IN-9 Biological Activity

Description Tubulin polymerization-IN-9 is a potent tubulin inhibitor with IC50 of 1.82 μM. Tubulin polymerization-IN-9 causes cell cycle arrest at G2/M phase, and induces cell apoptosis and depolarized mitochondria of K562 cells. Tubulin polymerization-IN-9 has potent anti-vascular and antitumor activities[1].
Related Catalog
Target

IC50: 1.82 μM (tubulin)[1]

In Vitro Tubulin polymerization-IN-9 (compound 11k) (0.1, 1, 10 μM; 72 hours) has potent activity against these three cancer cell lines with IC50 values ranging from 0.287 to 0.621 μM[1]. Tubulin polymerization-IN-9 (0.15, 0.3 and 0.6 μM; 24 hours) induces a dose-dependent collapse of the microtubule networks[1]. Tubulin polymerization-IN-9 (0.15, 0.3 and 0.6 μM; 48 hours) observes a gradual accumulation of cells at G2/M phase in K562 cells[1]. Tubulin polymerization-IN-9 (0.15, 0.3 and 0.6 μM; 72 hours) effectively induces cell apoptosis in K562 cells in a concentration-dependent manner[1]. Tubulin polymerization-IN-9 (0.15, 0.3 and 0.6 μM; 24 hours) causes mitochondrial depolarization of K562 cells in the process of apoptosis[1]. Cell Proliferation Assay Cell Line: K562 HepG2 and HCT-8 cells[1] Concentration: 0.1, 1, 10 μM Incubation Time: 72 hours Result: Showed potent activity against these three cancer cell lines with IC50 values ranging from 0.287 to 0.621 μM. Immunofluorescence Cell Line: K562 cells[1] Concentration: 0.15, 0.3 and 0.6 μM Incubation Time: 24 hours Result: Induced a dose-dependent collapse of the microtubule networks. Cell Cycle Analysis Cell Line: K562 cells[1] Concentration: 0.15, 0.3 and 0.6 μM Incubation Time: 48 hours Result: Observed a gradual accumulation of cells at G2/M phase in K562 cells. Apoptosis Analysis Cell Line: K562 cells[1] Concentration: 0.15, 0.3 and 0.6 μM Incubation Time: 72 hours Result: Effectively induced cell apoptosis in K562 cells in a concentration-dependent manner.
In Vivo Tubulin polymerization-IN-9 (15 and 30 mg/kg; IV; once a day, for 21 days) effectively suppresses the tumor volume and reduces tumor weight by 71.1% at a dose of 30 mg/kg[1]. Animal Model: Male ICR mice (5 weeks; injected with H22 cells; n=6)[1] Dosage: 15 and 30 mg/kg Administration: IV; once a day, for 21 days Result: Effectively suppressed the tumor volume and reduced tumor weight by 71.1% at a dose of 30 mg/kg.
References

[1]. Zhu H, Sun H, Liu Y, et al. Design, synthesis and biological evaluation of vinyl selenone derivatives as novel microtubule polymerization inhibitors. Eur J Med Chem. 2020;207:112716.

 Chemical & Physical Properties

Molecular Formula C19H19NO5Se
Molecular Weight 420.32